Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-118990
Filing Date
2024-10-30
Accepted
2024-10-30 16:10:24
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrn-20240930.htm   iXBRL 10-Q 2357530
2 EX-10.1 amrn-ex10_1.htm EX-10.1 18309
3 EX-31.1 amrn-ex31_1.htm EX-31.1 11727
4 EX-31.2 amrn-ex31_2.htm EX-31.2 12172
5 EX-32.1 amrn-ex32_1.htm EX-32.1 11799
6 GRAPHIC img153238507_0.jpg GRAPHIC 138672
7 GRAPHIC img195770556_0.jpg GRAPHIC 6481
  Complete submission text file 0000950170-24-118990.txt   10159966

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20240930.xsd EX-101.SCH 1328179
76 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20240930_htm.xml XML 1844789
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 241410399
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)